SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3dak'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1EA1_A_TPFA470_1 (CYTOCHROME P450 51-LIKE RV0764C)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	4 / 8	PHE A 290 MET A 267 PHE A 213 LEU A 220	None	1.18A	1ea1A-3dakA: undetectable	1ea1A-3dakA: 21.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_B_B49B1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	6 / 10	ILE A 23 VAL A 31 ALA A 44 LEU A 94 LEU A 153 ASP A 164	ANP A 1 (-4.2A) ANP A 1 (-4.5A) ANP A 1 ( 3.9A) None None ANP A 1 (-3.8A)	0.81A	2y7jB-3dakA: 25.0	2y7jB-3dakA: 26.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_C_B49C1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	6 / 10	ILE A 23 VAL A 31 ALA A 44 LEU A 94 ASP A 102 LEU A 153	ANP A 1 (-4.2A) ANP A 1 (-4.5A) ANP A 1 ( 3.9A) None None None	0.81A	2y7jC-3dakA: 24.9	2y7jC-3dakA: 26.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_C_B49C1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	6 / 10	VAL A 31 ALA A 44 LEU A 94 GLY A 98 ASP A 102 LEU A 153	ANP A 1 (-4.5A) ANP A 1 ( 3.9A) None None None None	0.90A	2y7jC-3dakA: 24.9	2y7jC-3dakA: 26.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_D_B49D1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	6 / 10	ILE A 23 VAL A 31 ALA A 44 LEU A 94 ASP A 102 LEU A 153	ANP A 1 (-4.2A) ANP A 1 (-4.5A) ANP A 1 ( 3.9A) None None None	0.91A	2y7jD-3dakA: 24.5	2y7jD-3dakA: 26.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GP0_A_NILA1_2 (MITOGEN-ACTIVATED PROTEIN KINASE 11)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	4 / 7	LYS A 46 LEU A 90 LEU A 94 ILE A 162	ANP A 1 (-2.8A) None None None	0.91A	3gp0A-3dakA: 19.8	3gp0A-3dakA: 29.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UG2_A_IREA1_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	7 / 12	VAL A 31 ALA A 44 LYS A 46 LEU A 90 MET A 92 LEU A 94 ASP A 102	ANP A 1 (-4.5A) ANP A 1 ( 3.9A) ANP A 1 (-2.8A) None None None None	0.81A	3ug2A-3dakA: 20.8	3ug2A-3dakA: 26.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4I22_A_IREA9001_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	8 / 12	GLY A 24 VAL A 31 ALA A 44 LYS A 46 LEU A 90 ASP A 102 LEU A 153 ASP A 164	ANP A 1 (-3.3A) ANP A 1 (-4.5A) ANP A 1 ( 3.9A) ANP A 1 (-2.8A) None None None ANP A 1 (-3.8A)	0.87A	4i22A-3dakA: 22.7	4i22A-3dakA: 26.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4I22_A_IREA9001_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	8 / 12	GLY A 24 VAL A 31 ALA A 44 LYS A 46 LEU A 90 MET A 92 ASP A 102 ASP A 164	ANP A 1 (-3.3A) ANP A 1 (-4.5A) ANP A 1 ( 3.9A) ANP A 1 (-2.8A) None None None ANP A 1 (-3.8A)	0.89A	4i22A-3dakA: 22.7	4i22A-3dakA: 26.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4I41_A_MIXA500_1 (SERINE/THREONINE-PRO TEIN KINASE PIM-1)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	7 / 12	VAL A 31 ALA A 44 ASP A 102 ASP A 146 LYS A 148 ASN A 151 LEU A 153	ANP A 1 (-4.5A) ANP A 1 ( 3.9A) None ANP A 1 (-4.3A) ANP A 1 ( 4.8A) ANP A 1 ( 3.4A) None	0.70A	4i41A-3dakA: 22.7	4i41A-3dakA: 26.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IFG_A_1E8A601_1 (CALMODULIN-DOMAIN PROTEIN KINASE 1)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	7 / 12	GLY A 24 VAL A 31 ALA A 44 LYS A 46 LEU A 90 GLY A 98 LEU A 153	ANP A 1 (-3.3A) ANP A 1 (-4.5A) ANP A 1 ( 3.9A) ANP A 1 (-2.8A) None None None	0.50A	4ifgA-3dakA: 23.9	4ifgA-3dakA: 24.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O0S_A_ADNA500_1 (AURORA KINASE A)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	7 / 11	GLY A 24 VAL A 31 ALA A 44 LYS A 46 ASN A 151 LEU A 153 ASP A 164	ANP A 1 (-3.3A) ANP A 1 (-4.5A) ANP A 1 ( 3.9A) ANP A 1 (-2.8A) ANP A 1 ( 3.4A) None ANP A 1 (-3.8A)	0.95A	4o0sA-3dakA: 25.7	4o0sA-3dakA: 27.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O0U_A_ADNA501_1 (AURORA KINASE A)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	4 / 6	VAL A 31 ALA A 44 LYS A 46 LEU A 153	ANP A 1 (-4.5A) ANP A 1 ( 3.9A) ANP A 1 (-2.8A) None	0.70A	4o0uA-3dakA: 6.9	4o0uA-3dakA: 27.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OGR_I_ADNI401_1 (CYCLIN-DEPENDENT KINASE 9)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	6 / 9	ILE A 23 VAL A 31 ALA A 44 ASN A 151 LEU A 153 ASP A 164	ANP A 1 (-4.2A) ANP A 1 (-4.5A) ANP A 1 ( 3.9A) ANP A 1 ( 3.4A) None ANP A 1 (-3.8A)	0.99A	4ogrI-3dakA: 21.3	4ogrI-3dakA: 27.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4QMZ_A_B49A401_1 (SERINE/THREONINE-PRO TEIN KINASE 24)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	7 / 12	ILE A 23 GLY A 24 VAL A 31 ALA A 44 MET A 92 LEU A 95 LEU A 153	ANP A 1 (-4.2A) ANP A 1 (-3.3A) ANP A 1 (-4.5A) ANP A 1 ( 3.9A) None ANP A 1 (-4.1A) None	0.76A	4qmzA-3dakA: 26.8	4qmzA-3dakA: 44.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RZ7_A_1E8A901_1 (CGMP-DEPENDENT PROTEIN KINASE, PUTATIVE)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	5 / 10	ILE A 23 ALA A 44 LYS A 46 LEU A 94 LEU A 153	ANP A 1 (-4.2A) ANP A 1 ( 3.9A) ANP A 1 (-2.8A) None None	0.76A	4rz7A-3dakA: 6.4	4rz7A-3dakA: 18.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V04_A_0LIA1772_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	6 / 12	VAL A 31 ALA A 44 LEU A 137 HIS A 144 ALA A 163 GLY A 166	ANP A 1 (-4.5A) ANP A 1 ( 3.9A) None None MG A 296 ( 3.9A) None	0.71A	4v04A-3dakA: 21.3	4v04A-3dakA: 30.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V04_B_0LIB1771_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	5 / 12	ALA A 44 LEU A 137 HIS A 144 ALA A 163 GLY A 166	ANP A 1 ( 3.9A) None None MG A 296 ( 3.9A) None	0.76A	4v04B-3dakA: 21.8	4v04B-3dakA: 30.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4WAN_C_ACTC303_0 (BRANCHPOINT-BRIDGING PROTEIN)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	3 / 3	ASP A 205 ARG A 279 PRO A 276	None	0.99A	4wanC-3dakA: 0.7	4wanC-3dakA: 19.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DZK_4_BEZ4801_0 (ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1 ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 BEZ-LEU-LEU)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	4 / 5	LEU A 220 PHE A 264 ILE A 218 ILE A 268	None	1.06A	5dzk4-3dakA: undetectable 5dzkg-3dakA: undetectable 5dzkm-3dakA: undetectable 5dzkn-3dakA: undetectable	5dzk4-3dakA: 3.57 5dzkg-3dakA: 21.43 5dzkm-3dakA: 20.20 5dzkn-3dakA: 20.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L2I_A_LQQA900_1 (CYCLIN-DEPENDENT KINASE 6)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	7 / 12	ILE A 23 GLY A 24 VAL A 31 ALA A 44 VAL A 76 LEU A 153 ALA A 163	ANP A 1 (-4.2A) ANP A 1 (-3.3A) ANP A 1 (-4.5A) ANP A 1 ( 3.9A) None None MG A 296 ( 3.9A)	0.73A	5l2iA-3dakA: 5.5	5l2iA-3dakA: 26.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L2T_A_6ZZA900_1 (CYCLIN-DEPENDENT KINASE 6)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	7 / 12	ILE A 23 GLY A 24 VAL A 31 ALA A 44 VAL A 76 LEU A 153 ALA A 163	ANP A 1 (-4.2A) ANP A 1 (-3.3A) ANP A 1 (-4.5A) ANP A 1 ( 3.9A) None None MG A 296 ( 3.9A)	0.93A	5l2tA-3dakA: 22.1	5l2tA-3dakA: 26.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UL4_A_SAMA803_0 (OXSB PROTEIN)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	5 / 12	PHE A 264 ALA A 149 GLY A 214 ILE A 268 LEU A 257	None	1.08A	5ul4A-3dakA: 2.3	5ul4A-3dakA: 18.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VCY_A_DB8A401_2 (MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	4 / 4	VAL A 76 LEU A 94 ASN A 151 ASP A 164	None None ANP A 1 ( 3.4A) ANP A 1 (-3.8A)	1.19A	5vcyA-3dakA: 21.5	5vcyA-3dakA: 26.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDH_D_DAHD60_1 (PUTATIVE CYTOCHROME C)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	4 / 5	HIS A 144 MET A 67 ASN A 74 VAL A 76	None	1.41A	5xdhD-3dakA: undetectable	5xdhD-3dakA: 12.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YU9_A_1E8A1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	8 / 12	GLY A 24 VAL A 31 ALA A 44 LYS A 46 MET A 67 LEU A 90 LEU A 153 ASP A 164	ANP A 1 (-3.3A) ANP A 1 (-4.5A) ANP A 1 ( 3.9A) ANP A 1 (-2.8A) None None None ANP A 1 (-3.8A)	0.79A	5yu9A-3dakA: 22.7	5yu9A-3dakA: 15.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YU9_B_1E8B1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	9 / 12	GLY A 24 VAL A 31 ALA A 44 LYS A 46 MET A 67 LEU A 90 ASP A 102 LEU A 153 ASP A 164	ANP A 1 (-3.3A) ANP A 1 (-4.5A) ANP A 1 ( 3.9A) ANP A 1 (-2.8A) None None None None ANP A 1 (-3.8A)	0.98A	5yu9B-3dakA: 22.8	5yu9B-3dakA: 15.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YU9_C_1E8C1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	7 / 12	VAL A 31 ALA A 44 LYS A 46 MET A 67 LEU A 90 ASP A 102 ASP A 164	ANP A 1 (-4.5A) ANP A 1 ( 3.9A) ANP A 1 (-2.8A) None None None ANP A 1 (-3.8A)	0.83A	5yu9C-3dakA: 22.4	5yu9C-3dakA: 15.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YU9_C_1E8C1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	6 / 12	VAL A 31 ALA A 44 MET A 67 LEU A 90 GLY A 98 ASP A 164	ANP A 1 (-4.5A) ANP A 1 ( 3.9A) None None None ANP A 1 (-3.8A)	0.77A	5yu9C-3dakA: 22.4	5yu9C-3dakA: 15.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YU9_D_1E8D1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	6 / 12	VAL A 31 ALA A 44 LYS A 46 MET A 67 ASP A 102 ASP A 164	ANP A 1 (-4.5A) ANP A 1 ( 3.9A) ANP A 1 (-2.8A) None None ANP A 1 (-3.8A)	1.01A	5yu9D-3dakA: 22.7	5yu9D-3dakA: 15.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YU9_D_1E8D1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	6 / 12	VAL A 31 ALA A 44 LYS A 46 MET A 92 ASP A 102 ASP A 164	ANP A 1 (-4.5A) ANP A 1 ( 3.9A) ANP A 1 (-2.8A) None None ANP A 1 (-3.8A)	1.26A	5yu9D-3dakA: 22.7	5yu9D-3dakA: 15.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YU9_D_1E8D1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3dak	SERINE/THREONINE-PRO TEIN KINASE OSR1 (Homo sapiens)	6 / 12	VAL A 31 ALA A 44 MET A 67 GLY A 98 LEU A 153 ASP A 164	ANP A 1 (-4.5A) ANP A 1 ( 3.9A) None None None ANP A 1 (-3.8A)	0.84A	5yu9D-3dakA: 22.7	5yu9D-3dakA: 15.25

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1EA1_A_TPFA470_1","CYTOCHROME P450 51-LIKE RV0764C","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",4,"PHE A 290;MET A 267;PHE A 213;LEU A 220","None","1.18A","1ea1A-3dakA:undetectable","1ea1A-3dakA:21.51"],["2Y7J_B_B49B1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",6,"ILE A  23;VAL A  31;ALA A  44;LEU A  94;LEU A 153;ASP A 164","ANP A   1 (-4.2A);ANP A   1 (-4.5A);ANP A   1 ( 3.9A);None;None;ANP A   1 (-3.8A)","0.81A","2y7jB-3dakA:25.0","2y7jB-3dakA:26.77"],["2Y7J_C_B49C1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",6,"ILE A  23;VAL A  31;ALA A  44;LEU A  94;ASP A 102;LEU A 153","ANP A   1 (-4.2A);ANP A   1 (-4.5A);ANP A   1 ( 3.9A);None;None;None","0.81A","2y7jC-3dakA:24.9","2y7jC-3dakA:26.77"],["2Y7J_C_B49C1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",6,"VAL A  31;ALA A  44;LEU A  94;GLY A  98;ASP A 102;LEU A 153","ANP A   1 (-4.5A);ANP A   1 ( 3.9A);None;None;None;None","0.90A","2y7jC-3dakA:24.9","2y7jC-3dakA:26.77"],["2Y7J_D_B49D1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",6,"ILE A  23;VAL A  31;ALA A  44;LEU A  94;ASP A 102;LEU A 153","ANP A   1 (-4.2A);ANP A   1 (-4.5A);ANP A   1 ( 3.9A);None;None;None","0.91A","2y7jD-3dakA:24.5","2y7jD-3dakA:26.77"],["3GP0_A_NILA1_2","MITOGEN-ACTIVATED PROTEIN KINASE 11","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",4,"LYS A  46;LEU A  90;LEU A  94;ILE A 162","ANP A   1 (-2.8A);None;None;None","0.91A","3gp0A-3dakA:19.8","3gp0A-3dakA:29.77"],["3UG2_A_IREA1_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",7,"VAL A  31;ALA A  44;LYS A  46;LEU A  90;MET A  92;LEU A  94;ASP A 102","ANP A   1 (-4.5A);ANP A   1 ( 3.9A);ANP A   1 (-2.8A);None;None;None;None","0.81A","3ug2A-3dakA:20.8","3ug2A-3dakA:26.50"],["4I22_A_IREA9001_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",8,"GLY A  24;VAL A  31;ALA A  44;LYS A  46;LEU A  90;ASP A 102;LEU A 153;ASP A 164","ANP A   1 (-3.3A);ANP A   1 (-4.5A);ANP A   1 ( 3.9A);ANP A   1 (-2.8A);None;None;None;ANP A   1 (-3.8A)","0.87A","4i22A-3dakA:22.7","4i22A-3dakA:26.94"],["4I22_A_IREA9001_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",8,"GLY A  24;VAL A  31;ALA A  44;LYS A  46;LEU A  90;MET A  92;ASP A 102;ASP A 164","ANP A   1 (-3.3A);ANP A   1 (-4.5A);ANP A   1 ( 3.9A);ANP A   1 (-2.8A);None;None;None;ANP A   1 (-3.8A)","0.89A","4i22A-3dakA:22.7","4i22A-3dakA:26.94"],["4I41_A_MIXA500_1","SERINE\/THREONINE-PROTEIN KINASE PIM-1","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",7,"VAL A  31;ALA A  44;ASP A 102;ASP A 146;LYS A 148;ASN A 151;LEU A 153","ANP A   1 (-4.5A);ANP A   1 ( 3.9A);None;ANP A   1 (-4.3A);ANP A   1 ( 4.8A);ANP A   1 ( 3.4A);None","0.70A","4i41A-3dakA:22.7","4i41A-3dakA:26.45"],["4IFG_A_1E8A601_1","CALMODULIN-DOMAIN PROTEIN KINASE 1","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",7,"GLY A  24;VAL A  31;ALA A  44;LYS A  46;LEU A  90;GLY A  98;LEU A 153","ANP A   1 (-3.3A);ANP A   1 (-4.5A);ANP A   1 ( 3.9A);ANP A   1 (-2.8A);None;None;None","0.50A","4ifgA-3dakA:23.9","4ifgA-3dakA:24.86"],["4O0S_A_ADNA500_1","AURORA KINASE A","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",7,"GLY A  24;VAL A  31;ALA A  44;LYS A  46;ASN A 151;LEU A 153;ASP A 164","ANP A   1 (-3.3A);ANP A   1 (-4.5A);ANP A   1 ( 3.9A);ANP A   1 (-2.8A);ANP A   1 ( 3.4A);None;ANP A   1 (-3.8A)","0.95A","4o0sA-3dakA:25.7","4o0sA-3dakA:27.83"],["4O0U_A_ADNA501_1","AURORA KINASE A","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",4,"VAL A  31;ALA A  44;LYS A  46;LEU A 153","ANP A   1 (-4.5A);ANP A   1 ( 3.9A);ANP A   1 (-2.8A);None","0.70A","4o0uA-3dakA:6.9","4o0uA-3dakA:27.51"],["4OGR_I_ADNI401_1","CYCLIN-DEPENDENT KINASE 9","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",6,"ILE A  23;VAL A  31;ALA A  44;ASN A 151;LEU A 153;ASP A 164","ANP A   1 (-4.2A);ANP A   1 (-4.5A);ANP A   1 ( 3.9A);ANP A   1 ( 3.4A);None;ANP A   1 (-3.8A)","0.99A","4ogrI-3dakA:21.3","4ogrI-3dakA:27.03"],["4QMZ_A_B49A401_1","SERINE\/THREONINE-PROTEIN KINASE 24","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",7,"ILE A  23;GLY A  24;VAL A  31;ALA A  44;MET A  92;LEU A  95;LEU A 153","ANP A   1 (-4.2A);ANP A   1 (-3.3A);ANP A   1 (-4.5A);ANP A   1 ( 3.9A);None;ANP A   1 (-4.1A);None","0.76A","4qmzA-3dakA:26.8","4qmzA-3dakA:44.59"],["4RZ7_A_1E8A901_1","CGMP-DEPENDENT PROTEIN KINASE, PUTATIVE","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",5,"ILE A  23;ALA A  44;LYS A  46;LEU A  94;LEU A 153","ANP A   1 (-4.2A);ANP A   1 ( 3.9A);ANP A   1 (-2.8A);None;None","0.76A","4rz7A-3dakA:6.4","4rz7A-3dakA:18.18"],["4V04_A_0LIA1772_1","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",6,"VAL A  31;ALA A  44;LEU A 137;HIS A 144;ALA A 163;GLY A 166","ANP A   1 (-4.5A);ANP A   1 ( 3.9A);None;None; MG A 296 ( 3.9A);None","0.71A","4v04A-3dakA:21.3","4v04A-3dakA:30.46"],["4V04_B_0LIB1771_2","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",5,"ALA A  44;LEU A 137;HIS A 144;ALA A 163;GLY A 166","ANP A   1 ( 3.9A);None;None; MG A 296 ( 3.9A);None","0.76A","4v04B-3dakA:21.8","4v04B-3dakA:30.46"],["4WAN_C_ACTC303_0","BRANCHPOINT-BRIDGING PROTEIN","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",3,"ASP A 205;ARG A 279;PRO A 276","None","0.99A","4wanC-3dakA:0.7","4wanC-3dakA:19.86"],["5DZK_4_BEZ4801_0","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1;ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2;BEZ-LEU-LEU","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",4,"LEU A 220;PHE A 264;ILE A 218;ILE A 268","None","1.06A","5dzk4-3dakA:undetectable;5dzkg-3dakA:undetectable;5dzkm-3dakA:undetectable;5dzkn-3dakA:undetectable","5dzk4-3dakA:3.57;5dzkg-3dakA:21.43;5dzkm-3dakA:20.20;5dzkn-3dakA:20.20"],["5L2I_A_LQQA900_1","CYCLIN-DEPENDENT KINASE 6","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",7,"ILE A  23;GLY A  24;VAL A  31;ALA A  44;VAL A  76;LEU A 153;ALA A 163","ANP A   1 (-4.2A);ANP A   1 (-3.3A);ANP A   1 (-4.5A);ANP A   1 ( 3.9A);None;None; MG A 296 ( 3.9A)","0.73A","5l2iA-3dakA:5.5","5l2iA-3dakA:26.88"],["5L2T_A_6ZZA900_1","CYCLIN-DEPENDENT KINASE 6","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",7,"ILE A  23;GLY A  24;VAL A  31;ALA A  44;VAL A  76;LEU A 153;ALA A 163","ANP A   1 (-4.2A);ANP A   1 (-3.3A);ANP A   1 (-4.5A);ANP A   1 ( 3.9A);None;None; MG A 296 ( 3.9A)","0.93A","5l2tA-3dakA:22.1","5l2tA-3dakA:26.88"],["5UL4_A_SAMA803_0","OXSB PROTEIN","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",5,"PHE A 264;ALA A 149;GLY A 214;ILE A 268;LEU A 257","None","1.08A","5ul4A-3dakA:2.3","5ul4A-3dakA:18.22"],["5VCY_A_DB8A401_2","MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",4,"VAL A  76;LEU A  94;ASN A 151;ASP A 164","None;None;ANP A   1 ( 3.4A);ANP A   1 (-3.8A)","1.19A","5vcyA-3dakA:21.5","5vcyA-3dakA:26.63"],["5XDH_D_DAHD60_1","PUTATIVE CYTOCHROME C","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",4,"HIS A 144;MET A  67;ASN A  74;VAL A  76","None","1.41A","5xdhD-3dakA:undetectable","5xdhD-3dakA:12.93"],["5YU9_A_1E8A1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",8,"GLY A  24;VAL A  31;ALA A  44;LYS A  46;MET A  67;LEU A  90;LEU A 153;ASP A 164","ANP A   1 (-3.3A);ANP A   1 (-4.5A);ANP A   1 ( 3.9A);ANP A   1 (-2.8A);None;None;None;ANP A   1 (-3.8A)","0.79A","5yu9A-3dakA:22.7","5yu9A-3dakA:15.25"],["5YU9_B_1E8B1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",9,"GLY A  24;VAL A  31;ALA A  44;LYS A  46;MET A  67;LEU A  90;ASP A 102;LEU A 153;ASP A 164","ANP A   1 (-3.3A);ANP A   1 (-4.5A);ANP A   1 ( 3.9A);ANP A   1 (-2.8A);None;None;None;None;ANP A   1 (-3.8A)","0.98A","5yu9B-3dakA:22.8","5yu9B-3dakA:15.25"],["5YU9_C_1E8C1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",7,"VAL A  31;ALA A  44;LYS A  46;MET A  67;LEU A  90;ASP A 102;ASP A 164","ANP A   1 (-4.5A);ANP A   1 ( 3.9A);ANP A   1 (-2.8A);None;None;None;ANP A   1 (-3.8A)","0.83A","5yu9C-3dakA:22.4","5yu9C-3dakA:15.25"],["5YU9_C_1E8C1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",6,"VAL A  31;ALA A  44;MET A  67;LEU A  90;GLY A  98;ASP A 164","ANP A   1 (-4.5A);ANP A   1 ( 3.9A);None;None;None;ANP A   1 (-3.8A)","0.77A","5yu9C-3dakA:22.4","5yu9C-3dakA:15.25"],["5YU9_D_1E8D1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",6,"VAL A  31;ALA A  44;LYS A  46;MET A  67;ASP A 102;ASP A 164","ANP A   1 (-4.5A);ANP A   1 ( 3.9A);ANP A   1 (-2.8A);None;None;ANP A   1 (-3.8A)","1.01A","5yu9D-3dakA:22.7","5yu9D-3dakA:15.25"],["5YU9_D_1E8D1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",6,"VAL A  31;ALA A  44;LYS A  46;MET A  92;ASP A 102;ASP A 164","ANP A   1 (-4.5A);ANP A   1 ( 3.9A);ANP A   1 (-2.8A);None;None;ANP A   1 (-3.8A)","1.26A","5yu9D-3dakA:22.7","5yu9D-3dakA:15.25"],["5YU9_D_1E8D1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3dak","SERINE\/THREONINE-PROTEIN KINASE OSR1","Homo sapiens",6,"VAL A  31;ALA A  44;MET A  67;GLY A  98;LEU A 153;ASP A 164","ANP A   1 (-4.5A);ANP A   1 ( 3.9A);None;None;None;ANP A   1 (-3.8A)","0.84A","5yu9D-3dakA:22.7","5yu9D-3dakA:15.25"]]